Want to see GB:AOTI full AI Analyst Report?

AOTI, Inc. (AOTI) Price & Analysis

Q: What was AOTI, Inc.’s price range in the past 12 months?

AOTI, Inc. lowest share price was 25.00 p and its highest was 150.00 p in the past 12 months.

Q: What is AOTI, Inc.’s market cap?

AOTI, Inc.’s market cap is £138.27M.

Q: When is AOTI, Inc.’s upcoming earnings report date?

AOTI, Inc.’s upcoming earnings report date is May 03, 2027 which is in 194 days.

Q: How were AOTI, Inc.’s earnings last quarter?

AOTI, Inc. released its earnings results on Sep 30, 2026. The company reported 0.008 p earnings per share for the quarter.

Q: Is AOTI, Inc. overvalued?

According to Wall Street analysts AOTI, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Q: Does AOTI, Inc. pay dividends?

AOTI, Inc. does not currently pay dividends.

Q: What is AOTI, Inc.’s EPS estimate?

AOTI, Inc.’s EPS estimate is <0.01.

Q: How many shares outstanding does AOTI, Inc. have?

AOTI, Inc. has 106,359,160 shares outstanding.

Q: What happened to AOTI, Inc.’s price movement after its last earnings report?

AOTI, Inc. reported an EPS of 0.008 p in its last earnings report. Following the earnings report the stock price went same 0%.

Q: Which hedge fund is a major shareholder of AOTI, Inc.?

Currently, no hedge funds are holding shares in GB:AOTI

3 Followers

AOTI Stock Chart & Stats

97.50 p

0.00 p(0.00%)

At close: Aug 12 4:00 PM EDT

97.50 p

0.00 p(0.00%)

Day’s Range― - ―

52-Week Range25.00 p - 150.00 p

Previous CloseN/A

Volume8.62K

Average Volume (3M)135.60K

Market Cap

£138.27M

Enterprise Value35.01M

Total Cash (Recent Filing)£13.44M

Total Debt (Recent Filing)£21.19M

Price to Earnings (P/E)69.8

Beta0.26

Next Earnings

May 03, 2027

EPS Estimate

<0.01

Next Dividend Ex-DateN/A

Dividend YieldN/A

Share Statistics

EPS (TTM)0.02

Shares Outstanding106,359,160

10 Day Avg. Volume283,073

30 Day Avg. Volume135,605

Financial Highlights & Ratios

PEG Ratio-0.06

Price to Book (P/B)1.97

Price to Sales (P/S)0.57

P/FCF Ratio-5.76

Enterprise Value/Market CapN/A

Enterprise Value/RevenueN/A

Enterprise Value/Gross ProfitN/A

Enterprise Value/EbitdaN/A

Forecast

1Y Price Target

£97.00

Price Target Upside-0.51% Downside

Rating ConsensusModerate Buy

Number of Analyst Covering1

EPS Forecast (FY)<0.01

Revenue Forecast (FY)£71.75M

Bulls Say, Bears Say

Bulls Say

Revenue Growth And Improving ProfitabilityRapid revenue expansion alongside a move to positive operating profit, EBITDA, and net income indicates improving scale economics. If growth continues, higher utilization and operating leverage could strengthen earnings power and support further investment in market development.

Clinical Evidence Supports AdoptionEvidence across more than 3,000 patients can strengthen clinician confidence and payer engagement because it supports both healing and durability. A credible outcomes base may improve adoption of TWO2 and reinforce differentiation in chronic wound care over time.

Recurring Consumables Revenue ModelThe device-and-consumables model can create recurring revenue beyond the initial system sale or rental. As the installed base expands and treatment utilization grows, ongoing consumable purchases may improve customer lifetime value and make revenue more durable.

Bears Say

Weak Historical Cash ConversionPersistent negative operating and free cash flow means recent accounting profitability has not yet translated into internally generated cash. Until conversion improves sustainably, AOTI may have less flexibility to fund growth and could remain more dependent on financing.

Arizona Medicaid Receivable And Intake RiskUncollected Arizona Medicaid revenue and halted new patient intake create an ongoing headwind to reported growth and cash realization. The uncertainty around recovery timing also complicates planning and has already required revised loan covenants.

Uncertain Medicare Reimbursement EconomicsProposed CMS coverage could expand the market substantially, but the unresolved payment level leaves adoption economics uncertain for providers and AOTI. Reimbursement below expectations could limit utilization, delay scaling, or reduce the benefit of broader coverage.

AOTI, Inc. News

AOTI, Inc. Earnings Call Highlights Growth And CMS Pivot

AOTI, Inc. (($GB:AOTI)) has held its Q2 earnings call. Read on for the main highlights of the call....

20d ago

AOTI

AOTI builds momentum ahead of transformative Medicare decision as H1 revenue and EBITDA climb

AOTI, Inc. ( ($GB:AOTI) ) has provided an update. AOTI reported robust underlying performance for the first half...

22d ago

AOTI Gains Unanimous Support in CMS Meeting on Medicare Coverage for Topical Oxygen Therapy

AOTI, Inc. ( ($GB:AOTI) ) has provided an update. AOTI, Inc., a medical technology group specializing in topical...

2M ago

AOTI Executives Boost Holdings Through Employee Share Purchase Plan

AOTI, Inc. ( ($GB:AOTI) ) has shared an announcement. AOTI, Inc. has reported purchases of its common shares...

3M ago

AOTI posts robust H1 growth as proposed Medicare coverage promises to transform U.S. market for its wound therapy

AOTI, Inc. ( ($GB:AOTI) ) has shared an announcement. AOTI, Inc. reported approximately 10% year-on-year revenue growth to...

3M ago

AOTI Set for Major U.S. Market Expansion as CMS Backs Coverage for TWO2 Therapy

An update from AOTI, Inc. ( ($GB:AOTI) ) is now available. AOTI, a leading provider of outcomes-based wound...

3M ago

AOTI Director Increases Stake as Wound-Care Specialist Expands Global Reach

AOTI, Inc. ( ($GB:AOTI) ) just unveiled an update. AOTI, Inc., founded in 2006 and based in Oceanside,...

4M ago

AOTI Shareholders Back All AGM Resolutions, Expanding Capital Flexibility

AOTI, Inc. ( ($GB:AOTI) ) has issued an announcement. AOTI, Inc. reported that all 12 resolutions put to...

5M ago

AOTI launches employee share plan to align staff with growth strategy

AOTI, Inc. ( ($GB:AOTI) ) has shared an update. AOTI, Inc., the AIM-quoted medical technology group specialising in...

6M ago

AOTI’s At-Home Oxygen Therapy Delivers Strong Real-World Wound Healing Results

AOTI, Inc. ( ($GB:AOTI) ) has shared an announcement. AOTI, Inc., a medical technology group specializing in non-invasive...

6M ago

AOTI FAQ

What was AOTI, Inc.’s price range in the past 12 months?

AOTI, Inc. lowest share price was 25.00 p and its highest was 150.00 p in the past 12 months.

What is AOTI, Inc.’s market cap?

AOTI, Inc.’s market cap is £138.27M.

When is AOTI, Inc.’s upcoming earnings report date?

AOTI, Inc.’s upcoming earnings report date is May 03, 2027 which is in 194 days.

How were AOTI, Inc.’s earnings last quarter?

AOTI, Inc. released its earnings results on Sep 30, 2026. The company reported 0.008 p earnings per share for the quarter.

Is AOTI, Inc. overvalued?

According to Wall Street analysts AOTI, Inc.’s price is currently Overvalued. Get more investment ideas with TipRanks Premium

Does AOTI, Inc. pay dividends?

AOTI, Inc. does not currently pay dividends.

What is AOTI, Inc.’s EPS estimate?

AOTI, Inc.’s EPS estimate is <0.01.

How many shares outstanding does AOTI, Inc. have?

AOTI, Inc. has 106,359,160 shares outstanding.

What happened to AOTI, Inc.’s price movement after its last earnings report?

AOTI, Inc. reported an EPS of 0.008 p in its last earnings report. Following the earnings report the stock price went same 0%.

Which hedge fund is a major shareholder of AOTI, Inc.?

Currently, no hedge funds are holding shares in GB:AOTI

What is the TipRanks Smart Score and how is it calculated?

Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology

AOTI, Inc. Stock Smart Score

Neutral

Analyst Consensus

Moderate Buy

Average Price Target:
£97.00 (-0.51% Downside)

Technicals

Fundamentals

Return on Equity

14.00%

Trailing 12-Months

Asset Growth

―

Trailing 12-Months

Learn more about TipRanks Smart Score

Top Smart Score Stocks >

Company Description

AOTI, Inc.

AOTI, Inc. specializes in creating and marketing healthcare technologies specifically designed for treating persistent and hard-to-heal wounds. Among its offerings are the innovative Topical Wound Oxygen (TWO2) Therapy and the NEXA Negative Pressure Wound Therapy (NPWT) System. Michael Stephen Griffiths founded the company in 2006, and its main office is located in Oceanside, California.

AOTI, Inc. (AOTI) Earnings & Revenues

Historic Earnings Reports

AOTI Stock 12 Month Forecast

Average Price Target

97.00 p

▼(-0.51% Downside)

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"26":"26 p","131":"131 p","52.25":"52.3 p","78.5":"78.5 p","104.75":"104.8 p"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":97,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">97.00 p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":97,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">97.00 p</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":97,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">97.00 p</span>\n  </div></div>","useHTML":true}}],"tickPositions":[26,52.25,78.5,104.75,131],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jan<br/>2026","6":"Apr<br/>2026","9":"Jul<br/>2026","12":"Oct<br/>2026","25":"Oct<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,130,127.46153846153847,124.92307692307692,122.38461538461539,119.84615384615384,117.3076923076923,114.76923076923077,112.23076923076923,109.6923076923077,107.15384615384616,104.61538461538461,102.07692307692308,99.53846153846155,{"y":97,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,130,127.46153846153847,124.92307692307692,122.38461538461539,119.84615384615384,117.3076923076923,114.76923076923077,112.23076923076923,109.6923076923077,107.15384615384616,104.61538461538461,102.07692307692308,99.53846153846155,{"y":97,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,130,127.46153846153847,124.92307692307692,122.38461538461539,119.84615384615384,117.3076923076923,114.76923076923077,112.23076923076923,109.6923076923077,107.15384615384616,104.61538461538461,102.07692307692308,99.53846153846155,{"y":97,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":42.5,"date":1759276800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":35,"date":1761955200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":36.5,"date":1764547200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":27.5,"date":1767225600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":41,"date":1769904000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":36.5,"date":1772323200000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":32.5,"date":1775001600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":63,"date":1777593600000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":59,"date":1780272000000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#828080","enabled":true,"symbol":"circle"}},{"y":62.5,"date":1782864000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":100,"date":1785542400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":125,"date":1788220800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 1,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":130,"date":1790812800000,"info":" <span style=\"color:#828080\" class=\"mb3 mt2 fonth8_semibold\"> Hold</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 0,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Detailed Analyst Forecast >